Results 31 to 40 of about 107,286 (246)

Heart failure with mid‐range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines

open access: yesESC Heart Failure, 2020
Currently, the assessment of left ventricular ejection fraction (LVEF) is the cornerstone of the classification of patients with heart failure (HF). The mid‐range LVEF (HFmrEF) category was identified in an attempt to uncover specific characteristics of ...
Luca Branca   +3 more
doaj   +1 more source

Treatment of Heart Failure with Preserved Ejection Fraction [PDF]

open access: yes, 2011
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90240/1/phco.31.3.312 ...
Barnes, Megan M.   +4 more
core   +1 more source

Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides

open access: yesFrontiers in Cardiovascular Medicine, 2021
This review summarizes current knowledge regarding clinical epidemiology, pathophysiology, and prognosis for patients with HFmrEF in comparison to HFrEF and HFpEF. Although recommended treatments currently focus on aggressive management of comorbidities,
Kaiyuan Zhu   +8 more
doaj   +1 more source

Heart failure with preserved ejection fraction and diabetes mellitus [PDF]

open access: yes, 2012
Heart failure with preserved ejection fraction (HFpEF) constitutes approximately 50% of heart failure patients. The prevalence of diabetes mellitus in HFpEF is high at 30-40%.
Cassar, Andrew   +3 more
core   +1 more source

Sex differences and atrial fibrillation in heart failure with reduced versus preserved ejection fraction [PDF]

open access: yes, 2021
Heart failure is a major public health problem. Patients with heart failure often experience dyspnoea, fatigue and/or have peripheral oedema. The prognosis of heart failure remains poor, with a severely impaired quality of life, frequent hospitalizations
Santema, Bernadet
core   +1 more source

Geographical Variations in Patients with Heart Failure and Preserved Ejection Fraction: A Sub-Group Analysis of the APOLLON Registry

open access: yesBalkan Medical Journal, 2019
Background: Clinical characteristics of patients with heart failure may vary geographically. However, limited data are available regarding the geographical differences of patients with heart failure and preserved ejection fraction.
Bülent Özlek   +19 more
doaj   +1 more source

Heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus: pathophysiology and treatment options

open access: yesМедицинский вестник Юга России, 2021
Type 2 diabetes mellitus is known to increase the risk of the development of heart failure with preserved ejection fraction and worsen its symptoms. To date, no specific treatment has been shown to reduce morbidity and mortality in patients with heart ...
A. A. Borisov   +2 more
doaj   +1 more source

Immunity, Inflammation and Heart Failure: Their Role on Cardiac Function and Iron Status [PDF]

open access: yes, 2019
Aims: Heart failure is a clinical syndrome characterized by subclinical systemic inflammation and immune system activation associated with iron deficiency.
Corrao S.   +10 more
core   +1 more source

Spironolactone for heart failure with preserved ejection fraction [PDF]

open access: yes, 2014
BACKGROUND: Mineralocorticoid-receptor antagonists improve the prognosis for patients with heart failure and a reduced left ventricular ejection fraction.
Anand, Inder S.   +24 more
core   +1 more source

Biomarkers in Heart Failure with Preserved Ejection Fraction

open access: yesCardiac Failure Review, 2022
Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous disorder developing from multiple aetiologies with overlapping pathophysiological mechanisms.
Antoni Bayes-Genis   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy